alexa A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs.
Infectious Diseases

Infectious Diseases

Journal of AIDS & Clinical Research

Author(s): Swinnen SG, Dain MP, Aronson R, Davies M, Gerstein HC, , Swinnen SG, Dain MP, Aronson R, Davies M, Gerstein HC,

Abstract Share this page

Abstract OBJECTIVE: To determine whether glargine is noninferior to detemir regarding the percentage of patients reaching A1C <7\% without symptomatic hypoglycemia This article was published in Diabetes Care and referenced in Journal of AIDS & Clinical Research

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords